Aiyar Ram 4

What Happened

• Aiyar Ram, President and CEO (also a director) of Korro Bio, received 50,000 shares of common stock on May 26, 2026. The shares were issued at a per-share value of $12.33, for a total reported value of $616,500. This transaction was an award/settlement of performance stock units (PSUs), not an open-market purchase or sale.

Key Details

• Transaction type/code: Award/Grant (coded "A" — settlement of PSUs)
• Transaction date: May 26, 2026; Form 4 filed May 28, 2026 (filed within the typical 2‑business‑day window)
• Price/value: $12.33 per share; total value $616,500
• Shares owned after transaction: Not specified in the provided excerpt of the filing
• Relevant footnotes:
  • F1: Shares issued upon settlement and vesting of a PSU granted under the company's 2023 Plan, vested upon achievement of performance condition on May 26, 2026.
  • F2: Includes 40,000 shares issuable upon settlement of a previously reported restricted stock unit (Form 4 dated Feb 3, 2026).
  • F3: Some shares are held by The Ram Aiyar Irrevocable Trust; the reporting person disclaims beneficial ownership except to the extent of pecuniary interest.

Context

• This was a compensation-related award (PSU vesting) — common for executives and not the same as an outright market purchase. Such awards reflect plan-driven vesting upon performance goals rather than a direct signal of buying or selling intent.
• The filing appears timely (reported two days after the transaction).